Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001829126-25-001429·Bio Green Med Solution, Inc.
Schedule 13D ownership disclosure
CYCLACEL PHARMACEUTICALS INC
Common Stock, par value $0.0001 per share · CUSIP: 23254L801
Event date: 2025-02-26
- Filing-level shares
- 194,628,820.00
- Percent of class
- 70.0%
- Doris Wong Sing EeReported CIK 0001892421
Shares: 194,628,820.00 · Class: 70.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001829126-25-001429
- Form type
- SCHEDULE 13D
- Filer
- Bio Green Med Solution, Inc.
- CIK
- CIK 1130166
- Filed
- Mar 04, 2025
- Reporting period
- Feb 26, 2025
- Description
- Schedule 13D beneficial ownership